A comparative meta-analysis of the efficacy of statin-ezetimibe co-therapy versus statin monotherapy in reducing cardiovascular and cerebrovascular adverse events in patients with type 2 diabetes mellitus.

Miao Xy, Liu Hz, Jin Mm, Sun Br, Haozhe Tian, Li J, Li N, Yan StPubMed 2019 · DOI

Abstract

Statin-ezetimibe co-therapy is found more efficacious than statin monotherapy in reducing the incidence of CVD with no significant difference between diabetic and non-diabetic individuals.
BibTeX
@inproceedings{xy2019comparative,
  author = {Miao Xy and Liu Hz and Jin Mm and Sun Br and Haozhe Tian and Li J and Li N and Yan St},
  title = {{A comparative meta-analysis of the efficacy of statin-ezetimibe co-therapy versus statin monotherapy in reducing cardiovascular and cerebrovascular adverse events in patients with type 2 diabetes mellitus.}},
  booktitle = {PubMed},
  year = {2019},
  doi = {10.26355/eurrev\_201903\_17279},
}

Loading related content...

Figure